Glenmark Pharmaceuticals Limited (NSE:GLENMARK)

Glenmark Pharmaceuticals Statistics

Total Valuation

NSE:GLENMARK has a market cap or net worth of INR 601.34 billion. The enterprise value is 609.01 billion.

Market Cap	601.34B
Enterprise Value	609.01B

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	Sep 15, 2025

Share Statistics

NSE:GLENMARK has 282.20 million shares outstanding. The number of shares has increased by 0.06% in one year.

Current Share Class	282.20M
Shares Outstanding	282.20M
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-2.85%
Owned by Insiders (%)	2.85%
Owned by Institutions (%)	32.21%
Float	142.26M

Valuation Ratios

The trailing PE ratio is 79.81 and the forward PE ratio is 27.33. NSE:GLENMARK's PEG ratio is 1.37.

PE Ratio	79.81
Forward PE	27.33
PS Ratio	4.47
PB Ratio	6.80
P/TBV Ratio	8.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.37

Enterprise Valuation

EV / Earnings	80.80
EV / Sales	4.53
EV / EBITDA	24.65
EV / EBIT	31.08
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.28
Debt / EBITDA	1.00
Debt / FCF	n/a
Interest Coverage	8.68

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	12.01%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	8.52M
Profits Per Employee	477,026
Employee Count	15,800
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:GLENMARK has paid 2.79 billion in taxes.

Income Tax	2.79B
Effective Tax Rate	26.98%

Stock Price Statistics

The stock price has increased by +24.95% in the last 52 weeks. The beta is 0.30, so NSE:GLENMARK's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+24.95%
50-Day Moving Average	2,027.18
200-Day Moving Average	1,620.84
Relative Strength Index (RSI)	67.16
Average Volume (20 Days)	788,263

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:GLENMARK had revenue of INR 134.56 billion and earned 7.54 billion in profits. Earnings per share was 26.70.

Revenue	134.56B
Gross Profit	91.97B
Operating Income	19.59B
Pretax Income	10.32B
Net Income	7.54B
EBITDA	24.71B
EBIT	19.59B
Earnings Per Share (EPS)	26.70

Balance Sheet

The company has 17.05 billion in cash and 24.73 billion in debt, giving a net cash position of -7.67 billion or -27.19 per share.

Cash & Cash Equivalents	17.05B
Total Debt	24.73B
Net Cash	-7.67B
Net Cash Per Share	-27.19
Equity (Book Value)	88.49B
Book Value Per Share	304.50
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 68.35%, with operating and profit margins of 14.56% and 5.60%.

Gross Margin	68.35%
Operating Margin	14.56%
Pretax Margin	7.67%
Profit Margin	5.60%
EBITDA Margin	18.36%
EBIT Margin	14.56%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.12%.

Dividend Per Share	2.50
Dividend Yield	0.12%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.06%
Shareholder Yield	0.06%
Earnings Yield	1.25%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.

Last Split Date	Sep 10, 2007
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	2